Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1670-1680
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1670
Table 2 Baseline data between modeling group and validation group (n = 195)
Index
Modeling group (n = 130)
Validation group (n = 65)
P value
Age (mean ± SD, yr)60.3 ± 11.860.8 ± 31.20.772
Gender, n (%)0.473
Man73 (56.2)40 (61.5)
Female57 (43.8)25 (38.5)
Primary tumor location, n (%)0.222
Colon62 (47.7)25 (38.5)
Rectum68 (52.3)40 (61.5)
BMI, M (P25, P75), kg/m222.3 (20.3, 24.9)22.0 (20.6, 25.0)0.992
TBIL, M (P25, P75), μmol/L13.3 (10.2, 18.0)14.0 (9.6, 18.7)0.825
DBIL, M (P25, P75), μmol/L4.7 (2.8, 7.3)3.9 (2.7, 7.1)0.462
IBIL, M (P25, P75), μmol/L8.7 (5.5, 11.9)9.6 (5.6, 13.0)0.412
ALT, M (P25, P75), U/L17.5 (11.0, 31.0)20.0 (11.0, 33.0)0.518
AST, M (P25, P75), U/L24.5 (17.0, 36.0)24.0 (17.5, 38.0)0.846
AST/ALT, M (P25, P75)1.4 (0.9, 1.8)1.4 (0.9, 1.9)0.715
TP, M (P25, P75), g/L68.3 (63.8, 72.9)67.1 (61.8, 73.0)0.348
ALB, M (P25, P75), g/L40.1 (35.8, 43.5)39.1 (36.8, 42.7)0.666
GLO, M (P25, P75), g/L28.7 (24.4, 32.4)28.4 (24.0, 31.4)0.556
A/G (mean ± SD)1.4 ± 0.41.4 ± 0.30.991
GGT, M (P25, P75), U/L22.5 (14.0, 52.3)22.0 (14.5, 40.5)0.828
ALP, M (P25, P75), U/L80.0 (63.8, 111.0)86.0 (67.0, 110.0)0.606
AFP, M (P25, P75), μg/L2.5 (1.7, 3.3)2.7 (1.6,3.2)0.607
CEA, M (P25, P75), μg/L4.7 (2.0, 33.3)5.3 (2.5, 35.3)0.514
CA125, M (P25, P75), U/mL12.6 (8.6, 23.2)31.2 (9.1, 22.7)0.792
CA19-9, M (P25, P75), U/mL13.9 (8.1, 52.6)15.2 (8.2, 52.4)0.697
ALBI score, M (P25, P75)-2.7 (-2.9, -2.3)-2.7 (-2.9, -2.4)0.522